X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Secrets to Longevity Explored in de novo Genome of 115-Year-Old Woman

Tuesday, November 10, 2020

Hendrikje van Andel-Schipper, at age 108

A new publication from scientists in The Netherlands and Belgium offers tantalizing insights that may shed light on age-related neurodegenerative disorders. The team used SMRT Sequencing to produce a de novo diploid assembly of the genome of a Dutch woman named Hendrikje van Andel-Schipper, who died at the age of 115 with no signs of cognitive decline, and then performed a detailed analysis of variants detected. The data are publicly available to the scientific community.

The paper, released in Translational Psychiatry, comes from lead author Jasper Linthorst and senior author Henne Holstege (@HolstegeHenne) at Amsterdam Neuroscience and their collaborators. They aimed to identify structural variants (SVs) that could be associated with the onset of neurological disorders; for this, they performed a comparison between several previously available human genome assemblies which included the centenarian genome assembly. 

The team chose long-read PacBio sequencing technology because they determined that “due to their repetitive nature, [SVs] are currently underexplored in short-read whole genome sequencing approaches,” they write. Repetitive regions, particularly repeat expansions that tend to grow larger over generations, have been shown to be pathogenic for a number of neurological diseases. “Using common sequencing approaches, the assessment of large repetitive regions is difficult because short 100-150 bp sequence-reads do not span the entire structural variant,” the authors report. “The solution to this problem is to generate longer sequencing reads.”

For this project, the scientists generated a de novo, phased genome assembly for the 115-year-old woman, which they refer to as W115. This was based on sequencing genomic DNA from three tissues and relied on FALCON-Unzip to create the diploid assembly of about 2.82 Gb. This information was compared to two haploid assemblies and the latest human reference genome to search for SVs of 50 bp or longer. 

The scientists used a graph-based multi-genome aligner called REVEAL and found a total of 31,680 SVs. Nearly 70% were classified as variable number tandem repeats (VNTRs). “Interestingly, we observed that VNTRs in the subtelomeric regions were composed of longer repeat subunits than VNTRs outside the subtelomeric regions, and that they had a higher GC-content,” they report. Expanded VNTRs have been linked to faulty gene transcription. “The genes that contained most VNTRs, of which PTPRN2 and DLGAP2 are the most prominent examples, were found to be predominantly expressed in the brain and associated with a wide variety of neurological disorders,” the scientists add.

Henne Holstege, Amsterdam Neuroscience

In addition, the team analyzed the list of structural variants to see how SMRT Sequencing had made a difference in detection. Using short-read data for the W115 genome only, they found just 5,826 SVs. About 83% of the SVs — that’s more than 18,000 variants — found in the PacBio assembly “were uniquely identified through long-read sequencing,” the scientists note.

The sequence data for this project was produced on a PacBio RS II system, but Holstege and her team have already acquired a Sequel II System for the next phase of this effort. That will involve a large study encompassing at least 150 cognitively healthy centenarians and 150 individuals with Alzheimer’s disease, with the goal of identifying VNTRs that have significantly different lengths between the two groups. Holstege and her team will be generating HiFi reads and they expect to cover each genome in the study with a single SMRT Cell. “We want to know what about these individuals makes them so special,” she told us.

 

Explore workflows and additional resources on comprehensive variant detection or structural variant detection.

Subscribe for blog updates:

Archives